We invest in technology and life sciences businesses in the U.S. and Europe through our offices in Boston, London, Munich, and Paris. We don’t just invest in companies. We partner with them. Our team’s purpose is to apply our operational and venture capital experience to help early-stage companies become successful, high-growth global businesses. Since we started in 1980, our Partners have helped build over 300 companies in more than 16 different countries. Since 1995, 44 of our companies have been acquired and 47 are now public companies with an aggregate market capitalization of over $15 billion. We are currently investing from our seventh fund and manage over $2 billion in capital